Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

medtech-houston-medtech-rodeo

Houston MedTech Rodeo brings investors, startups, corporates, and policymakers together for two days of healthcare innovation, partnerships, and Texas-sized networking.

Houston MedTech Rodeo

Summary

Speakers

Martin Gomez

Mayan Katz

Michael McGrail

Beni Surpin

Steven Tjoe

Matt Wetzel

Related Content

How Medicaid Cuts Could Reshape the Business of Health

What European Medtechs Should Know About the US Patent System

New Dental Industry Compliance Standards Take Shape: Dental Trade Alliance (DTA) Releases Revised Code of Ethics

US Emerging as Top Global Medtech Destination

Medtech M&A and VC Signal Positive Momentum Entering 2025

How the Trump Administration Could Reshape Regulation in the Life Sciences Sector

Fundraising Strategies for Early-Stage Medtech Startups

Medtech M&A and Venture Investments Show Renewed Strength

Vidi Capital Acquires the group CIL11

Goodwin Advises Boston Scientific in its Acquisition of Elutia Inc.’s BioEnvelope Business

MedTech and HealthTech in Focus

Goodwin Represents LumiThera in its Acquisition by Alcon

Goodwin Guides JotPsych in Securing $5M Seed Round

A Founder's Legal Playbook from a Healthtech Lawyer with Sophie McGrath, Partner at Goodwin (The HealthTech Podcast)

Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business For €760 Million

Goodwin Advises Absci on the Collaboration and $20 Million Strategic Investment with AMD to Accelerate the Future of AI Drug Discovery

Medtech